Loading Results

Clinical Trials

Showing   of 17 results

CID group logos

Cleveland Innovation District Partners Exceeding Many Targets Set by State and JobsOhio

25 examples of progress showcase the impact of successful collaboration.

Amrou Sarraj, MD

International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes

Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.

Harrington Discovery Institute

Harrington Discovery Institute Scholar Successfully Moves New Drug for Rare, Genetic Eye Disease into Clinical Trial

Richard Kramer, PhD, hopes to help patients with retinitis pigmentosa.

New Alzheimer's Disease Study Seeks Northeast Ohio Volunteers with Down Syndrome

As many as eight in 10 people with Down syndrome develop Alzheimer’s disease; new study needs volunteers to help identify causes and treatments

Clinical Trial Shows Injectable Weight Loss Drug Directly Reduces Abdominal Fat

Findings could potentially widen use for overweight adults who are high risk for heart disease.

UH Seidman-GenomOncology

New Technology Matching Patients Genomic Testing with Available Clinical Trials Nationwide Arrives at UH

Cleveland-based GenomOncology and UH Seidman Cancer Center enter into a market-leading partnership to increase clinical trial accrual rates.

UH Announces Participation in Novel Clinical Trial Testing Multiple Therapeutics to Treat COVID-19

University Hospitals adds ACTIV-2 Trial to arsenal of investigational treatments.

UH and CWRU Announce Study of AstraZeneca's COVID-19 Vaccine Candidate

Phase 3 clinical trial of AZD1222 uses a replication-deficient chimpanzee viral vector.

Results are loading...